Cathepsin-L (CTSL) is a member of the lysozomal cysteine protease family, which participates in remodelling of various tissues. Herein, we sought to examine the potential regulation of CTSL in cardiac remodelling post-infarction.
Introduction
Lysosomal cysteine proteases are ubiquitously expressed in different tissues and implicated in a variety of physiological and pathophysiological processes for their specific intra-and extracellular functions. 1, 2 Lysosomal alterations and increased lysosomal enzyme activity in blood or tissues after myocardial ischaemia or infarction have been documented in patients. 3, 4 Cathepsins belong to the papain-like family of lysosomal cysteine proteases, 5 which comprise 11 human and 19 murine enzymes. 6 Cathepsins participate in important biological functions, such as proteolytic processing of proenzymes, antigen presentation, extracellular matrix (ECM) and bone remodelling, cell invasion, tumour growth, and apoptosis. 7 -10 Cathepsin-L (CTSL) is known as a highly potent endoprotease of the cysteine cathepsin family. It is an ubiquitously expressed lysosomal enzyme, but has also been detected in the cytosol, nucleus, 11 and extracellular space. 12 Its multiple known diverse functions include the regulation of hair follicle cycling, epidermal homeostasis, major histocompatibility complex class II-mediated antigen presentation, tumour metastasis, and intracellular protein turnover. 13 -16 Previous work has demonstrated that CTSL is required for endothelial progenitor cell (EPC)-induced neovascularization, and CTSL deficiency causes a significant impairment of blood flow restoration in ischaemic limbs. 17 Deficiency of CTSL in mice results in progressive dilated cardiomyopathy (DCM) and can be partially rescued by crossing transgenic CTSL into Ctsl -/ -mice. 16, 18, 19 After myocardial injury such as myocardial infarction (MI), extensive remodelling takes place both in the myocytes and ECM. Adverse remodelling can set the stage for ventricular dysfunction and heart failure. In the current study, we sought to determine the role of CTSL in regulating and influencing cardiac repair/remodelling following injury using a well-established model of experimental MI 20, 21 in Ctsl -/ -and Ctsl +/+ mice and to elucidate the potential underlying mechanisms.
Methods

Animals
All experiments using mice were approved by and performed according to the Guidelines for the Care 20 and for details, see Supplementary material online.
Evaluation of ischaemia risk zone by Evans blue perfusion
At 48 h post-MI, the hearts were perfused with 1% Evans blue dye and fixed with 10% formalin for 48 h. The hearts were sliced transversely from the apex to the base of the LV at 1 mm thickness each. The sections were captured with a Nikon digital camera for quantitative analysis of the area at risk and infarct zone.
Detection of CTSL enzyme activity
CTSL proteolytic activity was determined in tissue lysates (50 mg protein) by degradation of the fluoropeptide Z-Phe-Arg-4-methyl-coumarin-7-amide (20 mM; Bachem) in the presence of the CTSB-specific inhibitor CA074 (1.5 mM; Bachem) at pH 5.5. The release of 7-amino-4-methylcoumarin was continuously monitored for 1 h by spectrofluorometry at excitation and emission wavelengths of 360 and 460 nm, respectively.
In vivo cardiac function measurements
Cardiac function was monitored non-invasively by echocardiographic imaging at 4 weeks after MI. Echocardiographic imaging was performed under light-controlled anaesthesia with isoflurane as previously described. 22 In vivo haemodynamic measurements were performed under light isoflurane anaesthesia in close-chested animals using a 1.4 French Millar catheter (Millar, Inc., Houston, TX, USA), and measurements were made as previously described. 23 
Cardiac morphometry
Morphometric analysis was performed on cardiac sections using a quantitative image digital analysis system (NIH image 1.6). Relative ventricular diameter, wall thickness, and infarct length were determined according to the method of Sun et al. 20 
Zymography
Protein was extracted with lysis buffer following homogenization. Samples (20 mg) were loaded onto each lane of 10% zymogram gelatin minigels (Novex, San Diego, CA). Gels were run at 35 mA for 2.5 h and then incubated in 2.5% Triton-X 100 for 2× 1 h at room temperature, washed, and further incubated for 16 h in 50 mmol Tris-HCl buffer, pH 7.5, containing 200 mmol NaCl and 10 mmol CaCl 2 at 378C. Gels were stained for 90 min in Coomassie blue and destained in 30% methanol/10% acetic acid for 60 min. White bands on a blue background indicated zones of digestion corresponding to the presence of different matrix metallopeptidases (MMPs) identified on the basis of their molecular weight. Bands were scanned using a densitometer (GS-700; Bio-Rad, Hercules, CA). MMP levels were quantified using the Multianalyst software (Bio-Rad).
Flow cytometric analysis
The sample collection tube was rinsed with 50 mL heparin (1000 mL/mL). 
Immunohistochemistry
Cryostat sections (5 mm) were prepared, air-dried, and fixed in 4% paraformaldehyde/phosphate-buffered saline for 15 min. The sections were incubated with 0.3% hydrogen peroxide and 10% bovine serum albumin for 15 min. They were then incubated with antibody against Mac3, CD31 (BD Pharmingen Technical, Mississauga, ON), C-kit (Abcom, CA), alpha-smooth muscle actin (a-SMA) (Sigma, MO), and Ki-67 (Bethyl Laboratories, TX) at 48C overnight. Finally, the sections were incubated with a matching biotinylated secondary antibody (Vector, Burlingame, CA) for 45 min at room temperature. Negative controls were performed for all immunologic staining by omission of the primary antibody.
Movat pentachrome staining
Cryostat sections (5 mm) were fixed in Bouin's solution for 30 min, followed by staining with Alcian Blue solution for 30 min. Slides were then washed in running water for 3 min and incubated with ammonium hydroxide in 95% alcohol (pH above 8) for 2 h. After washing with running water and rinsing in 70% alcohol, the slides were incubated with Weigert-Hart Resorcin solution for 3 h at 558C and then stained with Weigert's haematoxylin for 15 min. Next, they were rinsed with running water and stained with Woodstain Scarlet Fuchsin solution for 5 min, followed by rinsing in 0.5% aqueous glacial acetic acid. Slides were then rinsed thoroughly in three changes of absolute alcohol and incubated with alcoholic saffron for 15 min. This was followed by washing with four changes of absolute alcohol. Finally, the slides were washed with several changes of xylene and then mounted in Permount.
Cardiac collagen volume fraction
Cardiac collagen volume fraction was determined in sections stained with Movat Pentachrome. The cardiac collagen volume fraction was calculated as the ratio of the sum of total interstitial collagen area to the sum of total collagen and non-collagen area in the entire visual field of the section as previously reported. 23 
Statistical analysis
Data are expressed as mean + SEM. Differences among more than two groups were tested by one-way analysis of variance. Comparisons between two groups were performed by unpaired Student's t-test. A P-value less than 0.05 was considered significant.
Results
MI caused rapid CTSL activation in myocardium and bone marrow
The CTSL activity was significantly increased in the myocardium 24 h post-MI, peaking on day 3 in the ischaemic region. The activation of CTSL in the bone marrow followed a similar pattern, with CTSL activity significantly increasing at 6 h post-MI and maintaining a stable level thereafter ( Figure 1A) . No CTSL activity was detected in Ctsl -/ -mice.
CTSL deficiency predisposed to increased mortality at chronic phase after MI
The left anterior descending coronary artery ligation produced infarcts averaging 36 + 5.9% of the LV wall in both Ctsl +/+ and Ctsl -/ -mice ( Figure 1B ). Survival rate after MI was compared between Ctsl +/+ and Ctsl -/ -mice using Kaplan-Meier statistics ( Figure 1C ). After 4 weeks of MI, the survival rate was significantly lower in Ctsl -/ -mice (56%; 42 of 75) compared with Ctsl +/+ mice (80%; 40 of 50, P , 0.05), whereas the sham-operated mice of either genotype all survived.
CTSL deficiency contributed to diminished function and adverse remodelling late post-MI
Following MI, anatomical and pathological examination of Ctsl -/ -mice showed heart failure, as evidenced by pulmonary congestion and cardiac dilatation. M-mode echocardiography revealed exaggerated LV dilatation in Ctsl -/ -mice at week 4 post-MI ( Table 1) . Invasive pressure-volume measurements demonstrated that LV end-systolic pressure was significantly decreased, whereas LV end-systolic (LVESV) and end-diastolic volume (LVEDV) were significantly increased in Ctsl -/ -mice compared with Ctsl +/+ mice (P , 0.005).
Ejection fraction, positive dP/dt, and negative dP/dt were also significantly decreased in Ctsl -/ -mice (Supplementary material online, Figure S1 ). Ctsl -/ -and Ctsl +/+ mouse heart morphometry was assessed 28 days after MI (Figure 2A) . LV diameter was significantly increased (P , 0.001) in the Ctsl -/ -mice compared with Ctsl +/+ mice ( Figure 2B ). Concomitantly, infarcted segment thickness was reduced (P , 0.05) in Ctsl -/ -mice compared with Ctsl +/+ mice ( Figure 2C ).
We also evaluated the scar length as a percentage of the LV circumference by heart cross-section. 20 No difference was detected in scar length by day 7. Ctsl +/+ mice showed a relative stabilization between day 7 and day 14, whereas Ctsl -/ -mice showed continued infarct expansion ( Figure 2D , P , 0.001) until day 28. Heart/body weight and lung/body weight ratios were increased in Ctsl -/ -mice at day 28 ( Figure 2E and F ). Thus, impaired scar stability and progressive left ventricular dilatation after MI were likely contributing factors to the progression towards worsened cardiac dysfunction.
MMP-9 activation in myocardium and bone marrow correlated with CTSL activation post-MI
To elucidate the potential relationship between CTSL and MMP-9 activity (a major mediator of bone marrow cell mobilization), the timing of the MMP-9 expression patterns in the infarcted myocardium and bone marrow was analysed by zymography. As shown in Figure 3 , MMP-9 activity was significantly increased in the infarcted heart at 6 h in the Ctsl +/+ mice, reaching a peak at day 3, and decreasing thereafter. The sham group displayed very low levels of cardiac MMP-9, particularly in the Ctsl -/ -mice. Although MMP-9 activity in the Ctsl -/ -mice showed an increase, this was significantly diminished compared with Ctsl +/+ mice at 6 and 24 h (P , 0.001; Figure 3A ).
Bone marrow MMP-9 activity rapidly increased in Ctsl +/+ mice at 6 h and showed a delay of increase in Ctsl -/ -mice. After 24 h, there was no statistical difference between the two groups ( Figure 3B ). Figure 3C and Supplementary material online, Figure  S2 ). However, these differences were no longer significant by days Cathepsin-L and cardiac repair post-MI 7 and 14 (data not shown). Therefore, in the early phases after myocardial injury, CTSL likely played an important role in coordinating and enabling cell mobilization into circulation, ultimately homing into ischaemic tissues to participate in repair and restore function.
CTSL deficiency diminished cytokine expression and local homing response
Granulocyte-colony stimulating factor (G-CSF), stem cell factor (SCF), and stromal cell-derived factor-1 (SDF-1a) were significantly increased after MI in Ctsl +/+ mice. However, Ctsl -/ -mice showed significantly diminished levels of these cytokines at 55.1, 56 (P , 0.05), and 80% of Ctsl +/+ mice, respectively ( Figure 4A ) when compared 3 days post-MI. As these cytokines are also homing signals for inflammatory cells, immunostaining further elucidated the differences in local myocardial inflammatory infiltration. Figure 4B (a) depicts representative immunohistochemistry images of heart sections from Ctsl 
CTSL deficiency diminished myofibroblast population and proliferation, and impaired collagen & elastin deposition in the infarct scar
Myofibroblasts are the key cell population participating in the formation of the infarct scar. To further determine the mechanism of poor scar healing in Ctsl -/ -mice post-MI, immunostaining for a-SMA-positive (SMA + ) myofibroblasts was used to determine the response of the myofibroblasts in the infarcted myocardium. As shown in Figure 5A , at the infarct zone in the Ctsl +/+ mice, myofibroblasts first appeared by day 3, dominated at day 7, and remained abundant to day 14. However, Ctsl -/ -mice showed a significantly reduced SMA + cell population at 48, 77, and 50% of Ctsl +/+ mice on days 3, 7, and 14, respectively (P , 0.001; Figure 5B ). To further determine whether CTSL deficiency impaired myofibroblast proliferation, Figure 5B) . Thus, impaired myofibroblast response and proliferation in the infarct myocardium further impaired scar collagen and elastin deposition. As shown in Figure 5C , Movat staining demonstrated loose densities of collagen, thinner scar, and less elastin deposition in Ctsl -/ -mice ( Figure 5C(d -f) ). Quantitative collagen deposition in the infarct scar was significantly less when compared with Ctsl +/+ mice as well (P , 0.001; Figure 5D ). Thus, impaired myofibroblast response and proliferation is likely one of the factors that contribute to poor scar formation in Ctsl -/ -mice.
CTSL deficiency impaired infarcted myocardium blood vessels formation
As shown in Figure 6A , western blot analysis showed that endothelial vascular endothelial growth factor (VEGF) was enhanced in infarcted border region after MI in Ctsl +/+ mice. However, Ctsl -/ -mice showed significantly diminished levels of 52% when compared with Ctsl +/+ 3 days post-MI. Figure 6B showed the immunohistochemistry localized CD31 primarily to endothelial cells. At day 7 after MI, new vessels within the peri-infarct were strongly stained for CD31. Compared with Ctsl +/+ mice, the capillary density was significantly less, especially in the infarct border region of Ctsl -/ -mice. Quantitative capillary areas in the border zone are shown in Figure 6C . To further determine the fraction of proliferating endothelial cells in the infarcted myocardium, immunofluorescence for CD31 + / Ki67 + double-positive cells ( Figure 6B(c and f) ) were counted per microscopic field as shown in Figure 6C . Endothelial cell proliferation was noted to be significantly lower in number in Ctsl -/ -mice when compared with that in Ctsl +/+ mice (P , 0.001; Figure 6C) ; there was no difference in non-infarcted myocardium when compared with Ctsl +/+ myocardium.
Discussion
Cardiac repair/remodelling following MI is a highly complex process, involving peripheral blood or bone marrow cell mobilization and homing, activation of diverse inflammatory and growth factor signalling pathways, cell proliferation and death, and extensive myofibroblasts, microvascular, and ECM remodelling. 24 Although the mechanisms are not fully elucidated, preventing ventricular dilatation and preserving functional improvement are keys in preventing progression of heart failure. Cathepsins are cysteine proteases that participate in various types of tissue remodelling.
1,2 CTSL is known as a highly potent endoproteases of the cysteine cathepsin family and is ubiquitously expressed. Deficiency of CTSL in the heart primarily affects the lysosomal system, resulting in complex biochemical and cellular alterations which impair the structure and function of the lysosomal compartment in myocardium and contribute to spontaneously progressive DCM at aging. 18 We observed that CTSL activity was up-regulated after MI. In mice harbouring deficiency of the CTSL gene, the heart progressively dilated to congestive heart failure, associated with poor scar healing and doubling of the mortality post-MI when there was no gender differences in response to CTSL deletion. These findings suggest that CTSL is potentially one of the major coordinators for favourable repair and remodelling post-MI injury. The present study suggested that myocardium injury caused early CTSL release and may correlate with the increase in bone marrow CTSL and MMP-9 activation. CTSL and MMP-9 activation in the myocardium and bone marrow suggests that part of MMP-9 activation is associated with CTSL. Mechanistically, this is plausible as activated CTSL can cleave pro-urokinase-type plasminogen activator (uPA) into the active form, 25 which in turn is a potent activator of MMPs. 26, 27 On the other hand, inactive precursors of CTSL can also be activated by MMPs, 28 and thus complete the CTSL-uPA-MMP-CTSL positive feedback loop. Earlier increased CTSL are likely triggering MMP-9 activity contributing to the mobilization and recruitment of blood-or bone-marrow-derived accessory cells 29, 30 that can home to the ischaemic myocardium at acute stage after MI to mediate repair and remodelling. During later stages, the source of CTSL and MMP-9 in the local infarcted myocardium is from neutrophil granules as we and Entman's lab have shown previously. 20, 31 CTSL deficiency in contrast led to a relatively low MMP-9 level in local myocardium and bone marrow within 24 h of MI. This was associated with a significant impairment in recruitment of monocytes, natural killer cells, fibrocytes and c-kit positive cells in the peripheral circulation. This is consistent with earlier work by Urbich et al. 17 showing that CTSL play a role in the integration of circulating EPCs into ischaemic tissue. The local mobilization/homing signals G-CSF and SCF expression were also significantly diminished, and immunostaining of the injured myocardium confirmed decreased macrophage and c-kit positive cell homing post-MI to the myocardium in Ctsl -/ -mice. Previous studies suggested that the homing action of these cells can be assisted by proteolytic enzymes, which degrades the ECM to allow cells to migrate efficiently to the site of injury. 29 Increasing evidence also confirms the importance of these mobilized cells in the cardiac repair and remodelling post-MI, particularly in neovascularization and tissue regeneration. 17,32 -34 One of the key cell types involved in rebuilding and remodelling following MI are the myofibroblasts, which play a central role in Cathepsin-L and cardiac repair post-MI fibrogenesis. 35 Myofibroblast-mediated scar contracture is required to avoid the progressive thinning and dilatation that are the substrates for heart failure. 36 Increased accumulation of these cells in infarct zones has been associated with favourable cardiac remodelling and improved cardiac function. 37 -39 In addition, angiogenesis and granulation tissue formation are interlocking events in infarct repair 39, 40 and myofibroblasts are important cellular mediators in this response. They produce VEGF 41 and endothelin, 42 and have been suggested in turn to contribute to blood vessel formation. 37, 43, 44 Previous studies indicate that the circulating fibrocytes contribute to the myofibroblast population in the wounded tissue originate from the bone marrow. 45, 46 In this report, we evaluated whether a reduction in CTSL would impact fibrocyte mobilization and myofibroblast accumulation, thus contributing to cardiac dilatation and dysfunction. Indeed, the circulating fibrocyte population was significantly decreased in Ctsl -/ -mice when compared with Ctsl +/+ at day 3. Myofibroblast proliferation and accumulation were also diminished in the Ctsl -/ -mice subjected to infarction. Thus, deficiency of CTSL impaired fibrocyte mobilization, contributed to reduced myofibroblast accumulation, local proliferation, 47 and scar stabilization, which required to maintain structural integrity of the injured myocardium, and lead to progression to heart failure and increased mortality between 7 and 28 days post-MI. On the other hand, myofibroblasts have both beneficial and adverse effect. They are required for scar formation to maintain the integrity of the heart following MI. However, extensive fibrosis may increased the stiffness of the heart and contribute to ventricular dysfunction. Another important step in the wound-healing process is re-establishment of the capillary network, or angiogenesis. Angiogenesis is characterized by the invasion, migration, and proliferation of EPCs, endothelial cells, and smooth muscle cells. Decreased migration, infiltration, and proliferation of monocytes/macrophages, c-kit positive cells, and EPCs post-MI would reduce both indirect and direct angiogenesis. 48 In addition, CTSL is also encountered outside the cells or on the cell membrane 49 and can contribute to angiogenesis and recruitment of EPCs into the angiogenic region. 17 Recent studies demonstrated that CTSL and other cathepsins are highly expressed in various tumour cells and that inhibition of cathepsin activity reduced tumour vascularization and vascular branching. 9 Urbich et al. have reported that EPCs express high levels of CTSL which is essential for matrix degradation and invasion in vitro. Of important note, progenitor cells lacking CTSL do not home in to sites of ischaemia and do not augment neovascularization resulting impaired functional recovery following hind limb ischaemia. 17 In this study, angiogenesis after MI showed significant differences in the Ctsl -/ -and Ctsl +/+ mice. Deficiency of CTSL led to impairment in vascularization and significantly less capillary development in the infarct border zone at day 7 post-MI. Decreased endothelial cell proliferation was also observed in Ctsl -/ -mice. VEGF is important in signalling proteins involved in angiogenesis. However, Ctsl -/ -mice initially presented with a low level of VEGF which did not increase following MI. These data strengthen the fact that CTSL plays an essential role in angiogenesis during tissue repair, possibly through degradation of the vascular basement membrane and ECM, allowing progenitor cells to penetrate and home to injured area, enhance VEGF production and stimulates endothelial cell mitogenesis, cell migration, differentiation, and proliferation. These observations suggest CTSL contributes to angiogenesis in the infarct border zone as part of the remodelling process.
In this study, mice deficient in CTSL had a significantly impaired cardiac function after MI. This was accompanied by a diminished cell homing, impaired angiogenesis, and myofibroblast accumulation, leading to poor scar formation and cardiac dilatation. Thus, cardiac repair/remodelling benefits from activation of CTSL to improve remodelling and cardiac function after MI injury, and cathepsin L appear to be an important coordinator of the systemic response to cardiac injury.
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